Skip to Main Content

Paper Details

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma.
Transl Oncol
13
2016
BRAF, BRAF V600, BRAF V600 mutation, BRAF V600 mutations, BRAF-Mutated Melanoma, BRAFV600E, BRAFV600E mutations, Metastatic Melanoma, NF1, NF1 mutations, Patients, acral and mucosal melanoma, cutaneous melanoma, dabrafenib, melanoma, metastatic melanoma, mucosal/acral melanoma, noncutaneous melanoma, patients, vemurafenib
Author NameAffiliation
Kyung KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Nayoung K D KimSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 5

Datasets

Release 1.2